Skip to main content

Advertisement

Fig. 5 | Journal of Translational Medicine

Fig. 5

From: A novel gene-expression-signature-based model for prediction of response to Tripterysium glycosides tablet for rheumatoid arthritis patients

Fig. 5

ROC comparison of the six candidate gene biomarkers alone, their average expression level with the PLS-based model in predicting response to TG tablets. a ROC curves and AUC comparison results of MX1, OASL, SPINK1, CRK, GRAPL, RNF2, and the average of their expression levels using GAPDH as an internal control, as well as the PLS-based model in predicting response to TG tablets. b ROC curves and AUC comparison results of MX1, OASL, SPINK1, CRK, GRAPL, RNF2, and the average of their expression levels using RPS18 as an internal control, as well as the PLS-based model in predicting response to TG tablets

Back to article page